BLOGS WEBSITE
Category: International Funding
Templeton World Charity Foundation: Grand challenges for human flourishing
Templeton World Charity Foundation has launched a new strategy to support new scientific research on human flourishing and to translate related discoveries into practical tools. Over the next five years, the Foundation will support a range of projects across three distinct stages: discovery, development, and launch. Before picking a focal point for the discovery stage of this […]
Comments Off on Templeton World Charity Foundation: Grand challenges for human flourishing
Pfizer: PARP-inhibitor combination treatments in prostate cancer
Projects that will be considered for Pfizer support will focus on: Increasing understanding of the rationale for PARPi combinations as potential treatments for prostate cancer Increasing understanding of patient selection/identification for potential treatment with PARPi combinations for prostate cancer Increasing understanding of ongoing clinical trial design exploring PARPi combinations in prostate cancer Projects focusing on […]
Comments Off on Pfizer: PARP-inhibitor combination treatments in prostate cancer
NIH: National Institute on Alcohol Abuse & Alcoholism: Notice of special interest – alcohol & aging
The purpose of this notice of special interest (NOSI) is to promote research to improve our understanding of the effects of alcohol consumption on aging across different levels of biological organization including the molecular, cellular, tissue, organ, organism, and societal levels. The following broad research areas will be encouraged: Basic and clinical research defining the […]
Comments Off on NIH: National Institute on Alcohol Abuse & Alcoholism: Notice of special interest – alcohol & aging
Merck Sharp & Dohme (MSD): Oncology policy grant program
MSD Oncology is extending an open invitation to the Australian research community to participate in the MSD Oncology Grant Program. The grant aims to establish a global community of health policy researchers driving evidence-based and forward-looking health policy recommendations that will improve health outcomes for cancer patients. This competitive grant will be issued publicly and […]
Comments Off on Merck Sharp & Dohme (MSD): Oncology policy grant program
US Department of State – Department of Defence Science & Technology (DST): Fulbright Distinguished Chair in Advanced (Defence) Science and Technology
This scheme aims to attract outstanding U.S. researchers to work in Australia in priority areas of research for DST that will lead to ongoing collaborative partnerships between Australia and the U.S. and develop skills and capabilities in emerging fields of science and technology. The Fulbright Distinguished Chair will be appointed to the DST, or another […]
Comments Off on US Department of State – Department of Defence Science & Technology (DST): Fulbright Distinguished Chair in Advanced (Defence) Science and Technology
Department of Industry, Science, Energy & Resources (DISER): Joint research centres (JRCs)
The Department of Industry, Science, Energy and Resources (DISER), under the Australia-China Strategic Research Fund (ACSRF), invites applications for its Joint Research Centres (JRCs), to support strategic science, technology and innovation collaboration of mutual benefit to Australia and China. JRCs are virtual centres that link Australian and Chinese research institutions conducting a range of research-related […]
Comments Off on Department of Industry, Science, Energy & Resources (DISER): Joint research centres (JRCs)
Pfizer: Vaccine preventable diseases – COVID-19
The intent of this Request for Proposal (RFP) is to support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. We are particularly interested in supporting research in the following areas: Understanding impact of COVID on communities, spectrum of disease in communities, and level of herd immunity Postmortem Analysis of deceased […]
Comments Off on Pfizer: Vaccine preventable diseases – COVID-19
Pfizer Global Medical Grants: Increasing awareness of nuclear scintigraphy in cardiac amyloidosis
Projects that will be considered for Pfizer support will focus on increasing awareness of the role of nuclear scintigraphy (inclusive of Tc99m PYP, Tc-99m DPD and Tc-99m HDMP) in the diagnostic work up of patients with suspected cardiac amyloidosis along with other multimodality imaging techniques: Image acquisition and processing Image interpretation and reporting Common imaging […]
Comments Off on Pfizer Global Medical Grants: Increasing awareness of nuclear scintigraphy in cardiac amyloidosis
Pfizer’s Global Medical Grants: Long-acting Growth Hormone Research program
Projects that will be considered for Pfizer support will focus on long-acting growth hormone (LAGH) research, specifically: Morbidities in growth disorders Novel strategies including Quality of Life and Patient Reported Outcomes to evaluate and treat growth disorders Comparison of clinical effects of daily vs long-acting growth hormone Comparative pathophysiology of daily vs long-acting growth hormone […]
Comments Off on Pfizer’s Global Medical Grants: Long-acting Growth Hormone Research program
Pfizer’s Global Medical Grants: NASH – Future of Non-invasive Diagnosis Technologies
The submitted proposals should aim to inform the scientific and clinical community and to advance the discussion around non-invasive biomarkers and diagnostic tools for NASH (Nonalcoholic steatohepatitis). Funding & duration Up to US $250,000 (approx. AUD $387,000). Submission requirements & due date Applications must be submitted for internal review by 23 July 2020. Please email rbinternational@adelaide.edu.au if you are […]
Comments Off on Pfizer’s Global Medical Grants: NASH – Future of Non-invasive Diagnosis Technologies